2 Data from the largest clinical trial of GLP-1s to date (the SELECT trial of nearly 18,000 participants) showed in November 2023 that Wegovy (Novo Nordisks GLP-1 for weight loss) reduced heart attacks, strokes and deaths due to cardiovascular disease and 73% fewer patients progressed to diabetes vs
This recommendation is grounded in patient safety principles and evidence-based practice
Water, Centella Asiatica Extract (20.5%), Butylene Glycol, Glycerin, Dipropylene Glycol, Niacinamide (20,000ppm), Hydroxyethyl Urea, Sodium Hyaluronate, Allantoin, Panthenol, Glutathione (1,000ppm), Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Adenosine, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Xanthan Gum, Propanediol, Hydroxyacetophenone, 1,2-Hexanediol, Ethylhexylglycerin, Dipotassium Glycyrrhizate, Styrene/Acrylates Copolymer, Citric Acid, Sodium Citrate *For the most recent ingredient list, please consult the product packaging or contact us for a product photo.
This multi-pronged approach explains the unprecedented 24.2% weight loss observed in clinical trials
GADD34, growth arrest and DNA damage inducible gene 34
Himanshi Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016
